Evolus Inc Stock Performance

EOLS Stock  USD 4.32  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.76, which means possible diversification benefits within a given portfolio. As returns on the market increase, Evolus' returns are expected to increase less than the market. However, during the bear market, the loss of holding Evolus is expected to be smaller as well. At this point, Evolus Inc has a negative expected return of -0.61%. Please make sure to confirm Evolus' information ratio, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Evolus Inc performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Evolus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more

Actual Historical Performance (%)

One Day Return
(4.23)
Five Day Return
(1.38)
Year To Date Return
(36.01)
Ten Year Return
(62.61)
All Time Return
(62.61)
1
Evolus A Difficult 2025 Means Im Downgrading Stock To Hold For 2026 - Seeking Alpha
12/17/2025
2
Disposition of 2261 shares by Avelar Rui of Evolus at 7.1507 subject to Rule 16b-3
12/22/2025
3
Evolus Earns Hold Rating from Needham Company LLC
12/24/2025
4
Evolus Insider David Moatazedi Sells 10,5 Shares
12/30/2025
5
Insider Sellers Might Regret Selling Evolus Shares at a Lower Price Than Current Market Value
01/07/2026
6
Stifel Analyst Lowers Price Target on Evolus to 17.00 EOLS Stock News - GuruFocus
01/13/2026
7
Do Not Use - ocbj.com
01/16/2026
8
BTIG Research Cuts Evolus Price Target to 13.00
01/22/2026
9
H.C. Wainwright lowers Evolus stock price target to 13 on aesthetics headwinds - Investing.com Canada
02/03/2026
10
Mizuho Lowers Price Target on Evolus, Inc. to 15, Maintains Outperform Rating
02/09/2026
11
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
02/17/2026
Begin Period Cash Flow62.8 M
Total Cashflows From Investing Activities-4.8 M

Evolus Relative Risk vs. Return Landscape

If you would invest  652.00  in Evolus Inc on December 2, 2025 and sell it today you would lose (221.00) from holding Evolus Inc or give up 33.9% of portfolio value over 90 days. Evolus Inc is currently does not generate positive expected returns and assumes 3.1774% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Evolus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Evolus is expected to under-perform the market. In addition to that, the company is 4.19 times more volatile than its market benchmark. It trades about -0.19 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Evolus Target Price Odds to finish over Current Price

The tendency of Evolus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.32 90 days 4.32 
about 89.44
Based on a normal probability distribution, the odds of Evolus to move above the current price in 90 days from now is about 89.44 (This Evolus Inc probability density function shows the probability of Evolus Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Evolus has a beta of 0.76 suggesting as returns on the market go up, Evolus average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Evolus Inc will be expected to be much smaller as well. Additionally Evolus Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Evolus Price Density   
       Price  

Predictive Modules for Evolus

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evolus Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1.094.297.49
Details
Intrinsic
Valuation
LowRealHigh
3.646.8410.04
Details
Naive
Forecast
LowNextHigh
1.074.277.47
Details
7 Analysts
Consensus
LowTargetHigh
13.8015.1716.84
Details

Evolus Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Evolus is not an exception. The market had few large corrections towards the Evolus' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evolus Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evolus within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.72
β
Beta against Dow Jones0.76
σ
Overall volatility
1.12
Ir
Information ratio -0.23

Evolus Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evolus for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evolus Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Evolus Inc generated a negative expected return over the last 90 days
Evolus Inc has high historical volatility and very poor performance
Evolus Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 266.27 M. Net Loss for the year was (50.42 M) with profit before overhead, payroll, taxes, and interest of 190.45 M.
Evolus Inc currently holds about 84.48 M in cash with (18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51.
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026

Evolus Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Evolus Stock often depends not only on the future outlook of the current and potential Evolus' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evolus' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding62 M
Cash And Short Term Investments87 M

Evolus Fundamentals Growth

Evolus Stock prices reflect investors' perceptions of the future prospects and financial health of Evolus, and Evolus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evolus Stock performance.

About Evolus Performance

Assessing Evolus' fundamental ratios provides investors with valuable insights into Evolus' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Evolus is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 60.78  111.55 
Return On Tangible Assets(0.28)(0.29)
Return On Capital Employed(0.18)(0.19)
Return On Assets(0.25)(0.26)
Return On Equity(10.50)(9.98)

Things to note about Evolus Inc performance evaluation

Checking the ongoing alerts about Evolus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Evolus Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evolus Inc generated a negative expected return over the last 90 days
Evolus Inc has high historical volatility and very poor performance
Evolus Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 266.27 M. Net Loss for the year was (50.42 M) with profit before overhead, payroll, taxes, and interest of 190.45 M.
Evolus Inc currently holds about 84.48 M in cash with (18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51.
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
Evaluating Evolus' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Evolus' stock performance include:
  • Analyzing Evolus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evolus' stock is overvalued or undervalued compared to its peers.
  • Examining Evolus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Evolus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evolus' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Evolus' stock. These opinions can provide insight into Evolus' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Evolus' stock performance is not an exact science, and many factors can impact Evolus' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.